Creation of a production unit for hyaluronic acid-based medical devices (Q2910604): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 60.0 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||
| 3,341,866.2 Euro
| ||||||||||
| Property / priority axis | |||||||||||
| Property / priority axis: Enhancing the competitiveness of SMEs and reducing context-based public costs (TO 3 and TO2) / rank | |||||||||||
Normal rank | |||||||||||
| Property / co-financing rate | |||||||||||
60.0 percent
| |||||||||||
| Property / co-financing rate: 60.0 percent / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 01:49, 5 November 2022
Project Q2910604 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Creation of a production unit for hyaluronic acid-based medical devices |
Project Q2910604 in Portugal |
Statements
3,341,866.2 Euro
0 references
5,569,777.0 Euro
0 references
60.0 percent
0 references
1 January 2017
0 references
31 March 2019
0 references
BOHUS BIOTECH PORTUGAL LDA
0 references
38°57'8.06"N, 7°40'33.71"W
0 references
Sousel
0 references
Identifiers
POCI-02-0853-FEDER-018929
0 references